These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain. Zhang H; Wang Y; Chen Y; Sun S; Li N; Lv D; Liu C; Huang L; He D; Xiao X Lung Cancer; 2007 Jul; 57(1):37-45. PubMed ID: 17418446 [TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846 [TBL] [Abstract][Full Text] [Related]
26. Nuclear survivin as a biomarker for non-small-cell lung cancer. Lu B; Gonzalez A; Massion PP; Shyr Y; Shaktour B; Carbone DP; Hallahan DE Br J Cancer; 2004 Aug; 91(3):537-40. PubMed ID: 15266313 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860 [TBL] [Abstract][Full Text] [Related]
28. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099 [TBL] [Abstract][Full Text] [Related]
29. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung. Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP; Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401 [No Abstract] [Full Text] [Related]
30. [Subcellular localization of survivin in non-small cell lung cancer]. He L; Hou M; Zhang J; Xu N; Chen P Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914 [TBL] [Abstract][Full Text] [Related]
31. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer. Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764 [TBL] [Abstract][Full Text] [Related]
32. [Mesenchymal chondrosarcoma of the lung]. Dubova EA; Mishnev OD; Perepechin VI; Shchegolev AI Arkh Patol; 2008; 70(3):44-5. PubMed ID: 18727434 [TBL] [Abstract][Full Text] [Related]
33. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Chen W; Wang X; Zhuang J; Zhang L; Lin Y Carcinogenesis; 2007 Oct; 28(10):2114-21. PubMed ID: 17548900 [TBL] [Abstract][Full Text] [Related]
34. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells. Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429 [TBL] [Abstract][Full Text] [Related]
36. Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer. Massabeau C; Rouquette I; Lauwers-Cances V; Mazières J; Bachaud JM; Armand JP; Delisle MB; Favre G; Toulas C; Cohen-Jonathan-Moyal E Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):696-702. PubMed ID: 19386436 [TBL] [Abstract][Full Text] [Related]
37. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Stauber RH; Mann W; Knauer SK Cancer Res; 2007 Jul; 67(13):5999-6002. PubMed ID: 17616652 [TBL] [Abstract][Full Text] [Related]
38. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression. Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876 [TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor beta--which one and where should we draw the line? Shaaban AM; Speirs V Hum Pathol; 2006 Apr; 37(4):498; author reply 499-500. PubMed ID: 16564928 [No Abstract] [Full Text] [Related]
40. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Vischioni B; van der Valk P; Span SW; Kruyt FA; Rodriguez JA; Giaccone G Ann Oncol; 2004 Nov; 15(11):1654-60. PubMed ID: 15520067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]